VEANA THERAPEUTICS
Veana Therapeutics is a privately held Oregon-based biotechnology company whose business strategy is to identify ฮฑ-TEA-based cancer immunotherapy technologies. Veana Therapeutics is dedicated to developing innovative, safe, cancer-fighting immunotherapeutic products.
VEANA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Portland, Oregon, United States
Country:
United States
Website Url:
http://www.veana-therapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.82 M USD
Technology used in webpage:
Viewport Meta SPF Content Delivery Network LetsEncrypt SSL By Default HSTS Organization Schema Pound Sterling Typekit LocalBusiness Schema
Similar Organizations
24Genetics
24genetics.com is a biotechnology company specialized in Human Genetics.
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
F&S Pharmatech
Pharmaceutical technology company based in Nanjing.
Genetic Immunity Inc
Genetic Immunity Inc is a company that manufactures vaccines.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Triplebar
Triplebar provides sustainability, biotechnology, and synthetic biology research.
Xios Therapeutics
Xios Therapeutics is a biotechnology company .
Current Advisors List
Current Employees Featured
Founder
Investors List
Small Business Innovation Research
Small Business Innovation Research investment in Grant - Veana Therapeutics
BioRock Ventures Name
BioRock Ventures Name investment in Venture Round - Veana Therapeutics
National Cancer Institute SBIR Development Center
National Cancer Institute SBIR Development Center investment in Grant - Veana Therapeutics
Official Site Inspections
http://www.veana-therapeutics.com Semrush global rank: 15.92 M Semrush visits lastest month: 1
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Veana Therapeutics"
Veana Therapeutics, Inc.
Veana is a clinical stage company dedicated to developing innovative oral medicines for the treatment of cancer. Our medicines are designed to selectively target and destroy the energy โฆSee details»
Veana Overview - Veana Therapeutics, Inc.
Veana Therapeutics is dedicated to developing innovative, safe, cancer fighting medicines. Veanaโs VIMO technology is based on orally bioavailable anti-cancer agents that selectively attack and destroy the energy powerhouses โฆSee details»
Veana Therapeutics - Crunchbase Company Profile
Veana Therapeutics is a privately held Oregon-based biotechnology company whose business strategy is to identify ฮฑ-TEA-based cancer immunotherapy technologies. Veana Therapeutics is dedicated to developing innovative, safe, โฆSee details»
Team - Veana Therapeutics, Inc.
Chemistry, Manufacturing and Controls (CMC) expert with over 25 years pharmaceutical industry experience in formulation and development of small molecule new chemical entities.See details»
Organization | Veana Therapeutics, Inc.
Veana Therapeutics, Inc. Report issue For profit Phase 1 Founded: Portland OR United States (2012)See details»
Emmanuel Akporiaye - Founder & CEO at Veana Therapeutics
Dr. Emmanuel Akporiaye, Ph.D., is the Founder and CEO of Veana Therapeutics. He has over 30 years of immunotherapy experience specializing in the modulation of the tumor โฆSee details»
Emmanuel Akporiaye - Founder and CSO - Veana Therapeutics Inc โฆ
Nov 3, 2018ย ยท Veana is a clinical stage, research and development oncology company whose mission is to develop safer, and effective oral therapies that will improve and extend the lives โฆSee details»
Veana Therapeutics - Oregon Bioscience Association
V EANA THERAPEUTICS, INC is a privately held Oregon-based biotechnology company whose business strategy is to identify Alpha-TEA (vitamin E analog) cancer immunotherapy โฆSee details»
VEANA THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VEANA THERAPEUTICS, INC. of Portland, OR. Get the latest business insights from Dun & Bradstreet.See details»
Akporiaye | Scientists - Legacy Health
Dr. Akporiaye is the Founder and Chief Scientific Officer of Veana Therapeutics Inc., a biotechnology company founded as a spin-off from the Earle A. Chiles Research Institute of โฆSee details»
Veana Therapeutics - PitchBook
Operator of an early clinical-stage company intended to develop oral mitochondrial inhibitors for treating various cancers.See details»
Veana Technology - Veana Therapeutics, Inc.
Developing Effective and Safer Treatments for Cancer Patients. Technology. VIMO Technology. The companyโs VIMO technology consists of compounds that preferentially attack the โฆSee details»
Veana Therapeutics - Overview, News & Similar companies
Veana Therapeutics contact info: Phone number: (503) 869-0983 Website: www.veana-therapeutics.com What does Veana Therapeutics do? Established in 2012, Veana โฆSee details»
Veana Therapeutics - Contacts, Employees, Board Members
Veana Therapeutics has 1 current employee profile, Founder/CEO Emmanuel Akporiaye. Veana Therapeutics has 2 board members and advisors, including Sandra Shotwell.See details»
Novel breast cancer therapy candidate enters clinical study
Aug 14, 2020ย ยท Veana Therpeutics, Inc., and UW Medicine will collaborate on the clinical testing of Veanaโs lead agent โ an alpha TEA lysine salt, in combination with the monoclonal antibody, โฆSee details»
Veana Therapeutics LLC - Drug pipelines, Patents, Clinical trials
Explore Veana Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Drug:Alpha-Tocopheryloxyacetic acid.See details»
Collaborations โ Veana Therapeutics, Inc.
Veana Therapeutics partners with leading medical research institutions to advance the development of our VIMO technology platform. The company has an extensive research โฆSee details»
Veana Therapeutics, Inc. - Drug pipelines, Patents, Clinical
100 Clinical Results associated with Veana Therapeutics, Inc. BACKGROUND The pleiotropic cytokine, transforming growth factor (TGF)-ฮฒ, and CD4 + CD25 + Foxp3 + regulatory T cells โฆSee details»
Veana Therapeutics Announces Interim Results of the Phase I Trial โฆ
Apr 6, 2018ย ยท Veana Therapeutics, Inc. is pleased to announce the interim results of the Phase I safety trial of its lead cancer immunotherapy drug asset, VIMO-001, in patients with advanced โฆSee details»